← Back to Search

Memory, Attention, Problem Solving Skills in MS (MAPSS-MS) for Multiple Sclerosis

N/A
Waitlist Available
Led By Alexa Stuifbergen, PhD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-intervention
Awards & highlights

Summary

This trial tests a new program called MAPSS-MS to help people with multiple sclerosis (MS) improve their memory and thinking skills. The program includes group sessions and home computer exercises. It aims to help people with MS manage daily tasks better by teaching them new cognitive strategies.

Eligible Conditions
  • Multiple Sclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cognitive-related Instrumental Activities of Daily Living (IADL) Among Persons With MS
Neuro-cognitive Competence in Daily Living - California Verbal Learning Test-II
Use of Compensatory Cognitive Strategies
Secondary study objectives
Auditory Information Processing Speed and Flexibility
Nonverbal Learning and Memory
Psychomotor Processing Speed
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Memory, Attention, Problem Solving Skills in MS (MAPSS-MS)Experimental Treatment1 Intervention
Participants randomized to this arm receive the MAPSS-MS intervention. The MAPSS-MS is an an 8 week computer assisted cognitive rehabilitation intervention. The group based component of the intervention emphasizes use of compensatory cognitive strategies as well as lifestyle modifications to enhance cognition. Participants also complete home computer training (minimum 3 times per week for 45 minutes) using a special suite of games designed by Lumosity.
Group II: Usual Care plus Computer gamesActive Control1 Intervention
Participants randomized to this arm receive usual care and are referred to MY BRAIN GAMES web site.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MAPSS-MS
2014
N/A
~190

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
370 Previous Clinical Trials
83,003 Total Patients Enrolled
3 Trials studying Multiple Sclerosis
156 Patients Enrolled for Multiple Sclerosis
Alexa Stuifbergen, PhDPrincipal InvestigatorUniversity of Texas at Austin
~16 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top